Abstract
In a pilot study with five oral cancer patients undergoing radiotherapy (RT) three were given Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) as a protective agent to reduce the mucosal inflammation during radiotherapy. The myeloperoxidase (MPO) enzyme activity in WBC was quantitated. The three patients snowed a significant increase in the MPO activity when compared with two untreated controls indicating the efficacy of GM-CSF as a protective agent. It is suggested that further detailed studies with larger number of patients would be useful.
Original language | English |
---|---|
Pages (from-to) | 126-128 |
Number of pages | 3 |
Journal | Indian Journal of Clinical Biochemistry |
Volume | 13 |
Issue number | 2 |
DOIs | |
Publication status | Published - 01-01-1998 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Clinical Biochemistry